Kirkwood J, Del Vecchio M, Weber J, Hoeller C, et al. Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial. Nat Med 2023 Oct 16. doi: 10.1038/s41591-023-02583.
PMID: 37845511